---
figid: PMC9710342__bmjopen-2021-050590f01
pmcid: PMC9710342
image_filename: bmjopen-2021-050590f01.jpg
figure_link: /pmc/articles/PMC9710342/figure/F1/
number: Figure 1
figure_title: ''
caption: Patient pathway aligned with phase I trial. BFI, Brief Fatigue Inventory;
  COWA, Controlled Oral Word Association; CTMT, Comprehensive Trail Making Test; HADS,
  Hospital Anxiety and Depression Scale; HVLT-R, Hopkins Verbal Learning Test-Revised;
article_title: 'What is the impact of targeted therapies given within phase I trials
  on the cognitive function of patients with advanced cancer: a mixed-methods exploratory
  study conducted in an early clinical trials unit.'
citation: Sarah Stapleton, et al. BMJ Open. 2022;12(11):e050590.
year: '2022'

doi: 10.1136/bmjopen-2021-050590
journal_title: BMJ Open
journal_nlm_ta: BMJ Open
publisher_name: BMJ Publishing Group

keywords:
- clinical pharmacology
- adult oncology
- delirium & cognitive disorders
- clinical trials

---
